Two Republican senators are calling for the reauthorization of the Medical Device User Fee and Modernization Act (MDUFMA) as a catalyst for changes at the US Food and Drug Administration. In a letter addressed to the heads of life sciences industry organizations, Senators Richard Burr (R-NC) and Tom Coburn (R-OK) wrote that reauthorizing MDUFMA “provides an important opportunity to address the root causes of threats to our nation’s leadership in medical innovation.”
Read more: